Breast cancer is the most commonly diagnosed cancer and a leading cause of cancer-related death among women worldwide1 . Early detection and accurate diagnosis are critical to improving survival and quality of life2 . Treatment strategies have evolved to become more personalized and conservative, focusing on tumor biology and patient factors to optimize outcomes3 .
Breast Cancer Treatment Overview
Breast cancer treatment is tailored based on the cancer subtype, stage, and individual patient characteristics4 . The main treatment modalities include surgery, radiation therapy, systemic chemotherapy, hormone (endocrine) therapy, targeted drug therapies, and immunotherapy4 . Multidisciplinary teams collaborate to design personalized treatment plans that balance disease control with quality of life5 . Combination therapies and clinical trials play a vital role in advancing care, especially for aggressive or resistant cancers such as triple-negative breast cancer (TNBC) 67. Disparities in access to care affect outcomes, with vulnerable populations experiencing worse survival rates8 .
Surgical Procedures for Breast Cancer
Surgery remains a cornerstone of breast cancer management, primarily for early-stage disease9 . Surgical options depend on tumor size, location, lymph node involvement, and patient preferences10 . The goal is to remove the cancer while preserving as much healthy tissue as possible to maintain cosmetic outcomes and quality of life10 .
Sentinel lymph node biopsy
Sentinel lymph node biopsy involves removing the first lymph node(s) that drain the tumor area to assess cancer spread11 . It is the standard procedure for staging and guides decisions about further lymph node removal11 . If cancer cells are found in the sentinel node, additional lymph node dissection may be necessary11 .
Breast conserving surgery
Breast conserving surgery (BCS), also called lumpectomy or segmental mastectomy, removes the tumor and a margin of surrounding tissue while preserving most of the breast11 . BCS followed by radiation therapy is the intended surgical standard for most early breast cancers due to better cosmetic results and life satisfaction compared to mastectomy12 . This approach achieves similar long-term local control and survival rates12 .
Total mastectomy
Total mastectomy involves removal of the entire breast tissue11 . It is an option for patients with larger tumors, multifocal disease, or those who prefer mastectomy over breast conservation13 . Mastectomy may be performed with or without immediate breast reconstruction13 .
Modified radical mastectomy
Modified radical mastectomy includes removal of the breast and axillary lymph nodes11 . This procedure is often used when lymph node involvement is confirmed or suspected11 . It aims to achieve complete local control of the cancer while preserving the chest muscles11 .
Radical mastectomy
Radical mastectomy, a more extensive surgery removing the breast, axillary lymph nodes, and chest wall muscles, is rarely performed today due to advances in less invasive techniques11 . It is reserved for very advanced or recurrent cases where other options are insufficient11 .
Breast reconstruction surgery
Breast reconstruction can be performed at the time of mastectomy or later to restore breast shape13 . Options include implants or autologous tissue flaps such as the rectus muscle flap13 . Reconstruction improves psychological well-being and quality of life for many patients13 .
- Surgical management options for breast cancer include:
- Sentinel lymph node biopsy for staging11
- Breast conserving surgery with radiation for early tumors12
- Total mastectomy with or without reconstruction13
- Modified radical mastectomy for node-positive disease11
- Radical mastectomy reserved for advanced cases11
Related Stories
Radiation Therapy for Breast Cancer
Radiation therapy uses high-energy X-rays or other types of radiation to destroy cancer cells and prevent tumor growth11 . It is commonly used after breast conserving surgery to reduce the risk of local recurrence10 9. External beam radiation is the most frequent method, delivering radiation from outside the body to the tumor site9 . Internal radiation (brachytherapy), which places radioactive material near the tumor, is less common and mainly used for specific indications such as bone metastases9 .
Side effects of radiation therapy are generally localized and manageable, including skin irritation, inflammation, and fatigue9 . Postmastectomy radiation therapy (PMRT) is recommended for patients with multiple involved lymph nodes to improve local control12 .
- Radiation therapy benefits include:
- Reducing local recurrence after breast conserving surgery10
- Targeting residual microscopic disease in the breast and lymph nodes12
- Options include external beam radiation and brachytherapy9
- Side effects are mostly skin-related and temporary9
Chemotherapy Treatment Options
Chemotherapy uses drugs that kill or inhibit rapidly dividing cancer cells throughout the body14 . It is especially important for aggressive subtypes like triple-negative breast cancer and high-risk hormone receptor-positive cancers4 15. Chemotherapy can be given before surgery (neoadjuvant) to shrink tumors or after surgery (adjuvant) to reduce recurrence risk14 .
Because chemotherapy affects both cancerous and healthy dividing cells, it can cause side effects such as neutropenia (increased infection risk), mucositis (oral ulcers), thrombocytopenia (bleeding risk), and long-term effects including premature menopause and cardiotoxicity14 . Careful patient selection and supportive care are essential to manage these toxicities14 .
- Key points about chemotherapy in breast cancer:
- Systemic treatment targeting cancer cells body-wide14
- Used in neoadjuvant and adjuvant settings14
- Side effects include immune suppression, mucosal damage, and bleeding risks14
- Long-term risks require monitoring14
Hormone Therapy for Breast Cancer
Hormone therapy, or endocrine therapy, is effective for hormone receptor-positive breast cancers by blocking hormone production or receptor activity4 . Common agents include selective estrogen receptor modulators like tamoxifen and aromatase inhibitors4 16. Tamoxifen binds to estrogen receptors to inhibit tumor growth and is used in early and advanced disease4 .
Side effects vary by drug and patient sex. Women on tamoxifen require monitoring for a small increased risk of endometrial cancer and should report abnormal vaginal bleeding promptly17 . Hormone therapy may cause menopausal symptoms, cognitive changes, and bone loss4 . Male breast cancer patients on tamoxifen may experience gastrointestinal and sexual side effects18 .
- Hormone therapy facts:
- Targets estrogen and progesterone pathways to slow tumor growth4
- Includes tamoxifen and aromatase inhibitors4
- Used in adjuvant, neoadjuvant, and metastatic settings4
- Requires monitoring for specific side effects17
Targeted Drug Therapies
Targeted therapies focus on molecular abnormalities such as HER2 overexpression and hormone receptor pathways19 20. These drugs selectively inhibit pathways critical for cancer cell survival and proliferation, generally causing fewer side effects than chemotherapy19 . Classes include monoclonal antibodies (e.g., trastuzumab), tyrosine kinase inhibitors, CDK4/6 inhibitors, mTOR inhibitors, and PARP inhibitors4 19.
Monoclonal antibodies bind to cancer-specific antigens and are given intravenously19 . Tyrosine kinase inhibitors block signaling pathways essential for tumor growth19 . CDK inhibitors disrupt cell cycle progression, while PARP inhibitors exploit DNA repair defects to induce cancer cell death19 . Common adverse effects include gastrointestinal symptoms, fatigue, skin reactions, and rare cardiotoxicity19 .
- Targeted therapy highlights:
- Precision drugs aimed at specific molecular targets19
- Improved tolerability compared to chemotherapy19
- Includes monoclonal antibodies, TKIs, CDK4/6 inhibitors, and PARP inhibitors4 19
- Side effects vary but can include cardiotoxicity19
Immunotherapy for Breast Cancer
“Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.”
— Burstein H. J. 26
Immunotherapy harnesses the immune system to recognize and destroy cancer cells21 . It is particularly promising for triple-negative breast cancer and tumors with high mutation burden22 21. Immune checkpoint inhibitors, engineered T cells, and cancer vaccines are under active investigation23 24.
While immunotherapy can boost immune recognition of tumors, it is currently limited to select patient populations and may cause immune-related side effects such as inflammation and flu-like symptoms22 21. Ongoing research aims to expand its use and improve outcomes25 .
- Immunotherapy key points:
- Stimulates or enhances immune response against cancer21
- Effective mainly in aggressive subtypes like TNBC22
- Includes checkpoint inhibitors and cellular therapies23
- Side effects involve immune-related inflammation21
“Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.”
— Goldhirsch A. 26
Clinical Trials for Breast Cancer
Clinical trials are essential for developing new breast cancer therapies and improving existing treatments23 7. They follow rigorous preclinical testing and multiple phases to assess safety and efficacy7 . Patients at any stage of disease may be eligible to participate, gaining access to novel therapies while contributing to scientific progress23 7.
The National Cancer Institute and other organizations provide resources to locate appropriate clinical trials7 . Participation supports both personal treatment goals and advances in breast cancer care for all patients7 .
- Clinical trial essentials:
- Test new diagnostic and therapeutic approaches7
- Include preclinical and multiple clinical phases7
- Open to patients at various disease stages7
- Help advance breast cancer treatment broadly7
“Watson for oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board.”
— Somashekhar S. P. 26
Treatment Summary and Key Points
Breast cancer treatment has become increasingly personalized, integrating molecular diagnostics and patient factors to optimize outcomes5 . Surgery remains the foundation for early-stage disease, with breast conserving surgery plus radiation preferred for many patients12 . Systemic therapies such as chemotherapy, hormone therapy, targeted drugs, and immunotherapy are tailored based on tumor subtype and risk4 3.
Multidisciplinary care and patient education are critical to effective treatment planning and side effect management14 5. Despite advances, disparities in access and outcomes persist, highlighting the need for equitable care8 . Clinical trials continue to drive innovation and improve survival for all breast cancer patients7 .
- Key takeaways:
- Treatment depends on cancer subtype, stage, and patient preferences5
- Surgery options range from breast conservation to mastectomy12
- Systemic therapies include chemotherapy, hormone therapy, targeted therapy, and immunotherapy4
- Multidisciplinary teams ensure comprehensive care5
- Clinical trials are vital for advancing treatment7
